Apogenix AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.apogenix.com
Asunercept in Patients With Severe COVID-19
Phase 2
Completed
- Conditions
- COVID-19 Induced PneumoniaCovid19
- Interventions
- Biological: Asunercept
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Apogenix AG
- Target Recruit Count
- 438
- Registration Number
- NCT04535674
- Locations
- π·πΊ
State Budgetary Healthcare Institution "Scientific Research Institute - Regional clinical hospital No. 1 n.a. professor S.V. Ochapovsky" of the Ministry of Healthcare of Krasnodar Krai, Krasnodar, Russian Federation
π·πΊState Budgetary Institution of Health of the Nizhny Novgorod Region "Infectious Clinical Hospital No. 2 of Nizhny Novgorod", Nizhny Novgorod, Russian Federation
π·πΊRepublican Clinical Infectious Hospital n.a. professor A.F. Agafonov, Kazan, Russian Federation
Β© Copyright 2025. All Rights Reserved by MedPath